.Possession supervisor TPG, which has assisted biotechs such as Sionna Rehabs and Santa Clam Ana Bio...
.Merck & Co.'s TIGIT plan has endured one more drawback. Months after shuttering a stage 3 most c...
.After a year determined through pipe cuts, the shift of its own CEO as well as layoffs, Exscientia ...
.Cullinan Therapy was actually wowed enough with Port BioMed's bispecific immune system reactor that...
.In this particular full week's episode of "The Best Line," we're diving into Brutal Biotech's yearl...
.The confetti is still soaring from Eli Lilly's celebration commemorating the commendation of Alzhei...
.Invite to recently's Chutes & Ladders, our summary of significant management hirings, firings as...
.Observing an unsatisfactory showing for Lykos Therapies' MDMA candidate for trauma at a current FDA...
.AN2 Therapies is reconsidering its own organization in feedback to dull midphase data, pledging to ...
.Merck & Co. is spending $700 thousand beforehand to test Amgen in a blood cancer cells market. T...